Our study addresses this gap by identifying GPD1L, a gene recently implicated in obesity pathogenesis through genome-wide association studies (16), as a novel tumor suppressor in CRC, thereby providing mechanistic insights into obesity-driven oncogenesis. This evidence concerns the gene GPD1L and obesity due to melanocortin 4 receptor deficiency.